Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2807/esw.12.19.03190-en | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Implications of conflict on vaccination in the Sahel region.
BMJ Glob Health
January 2025
The University of Sydney School of Public Health, Sydney, New South Wales, Australia.
The Sahel region is a geographical belt in Africa that stretches from the Atlantic Ocean to the Red Sea, between the Sahara Desert in the north and the Savannah in the south. It is characterised by challenging environmental crises and conflicts. This analysis highlights the potential implications of conflict on vaccination across five Sahel countries, including Burkina Faso, Chad, Mali, Niger and Sudan, from 2019 to 2023.
View Article and Find Full Text PDFEpidemiology of measles clusters/outbreaks during 2016-2017 in Oman.
IJID Reg
March 2025
Director General for Disease Surveillance and Control, Ministry of Health, Muscat, Oman.
Objectives: The epidemiology of measles in Oman has shown a decreasing trend since the introduction of vaccines with high coverage, even at the district level. Oman achieved elimination status in 2019. Currently, measles epidemiology is characterized by a small number of imported and importation-related cases with limited spread in the community.
View Article and Find Full Text PDFGenetic characterization of measles virus circulating in Iran, 2021-2023.
BMC Infect Dis
January 2025
Department of Virology, School of Public Health, National Measles Laboratory (NML), Tehran University of Medical Sciences, Tehran, Iran.
Background: Measles, an ongoing public health concern, demands continuous molecular surveillance and virus characterization for elimination. Despite Iran achieving measles elimination status in 2019 through robust molecular testing and vaccination, the COVID-19 pandemic disrupted global vaccination efforts, leading to increased measles-related morbidity and mortality. This study aims to overview measles virus serological and molecular traits in Iran from 1st January 2021 to 30th April 2023.
View Article and Find Full Text PDFImmunisation schedule of the Pediatric Spanish Association: 2024 recommendations.
An Pediatr (Engl Ed)
January 2025
Pediatrician, Barcelona, Spain.
The AEP 2025 Vaccination and Immunization Schedule recommended for children, adolescents and pregnant women residing in Spain features the following novelties: Due to the increase in measles cases and outbreaks in recent years, we recommend advancing the second dose of measles, mumps and rubella (MMR) vaccine to 2 years of age. As a consequence of the above, since many autonomous communities (ACs) use the quadrivalent vaccine for the second dose of MMR and varicella vaccines, we recommend, for all ACs, advancing the second dose of varicella vaccine to 2 years of age. Due to the very significant increase in cases of pertussis since late 2023 and especially in 2024, we recommend advancing the dose of Tdap given in adolescence to 10-12 years of age.
View Article and Find Full Text PDFRevealing trends in measles immunity during periods of varying measles circulation in Madagascar.
Am J Epidemiol
January 2025
Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, USA.
Estimating the durability of immunity from vaccination is complicated by unreported re-vaccination, and unobserved natural infection or reexposure, which could result in overestimation of protection longevity. We tested serial cross-sectional serum samples from 2005 to 2015 (N=2,530) for IgG to examine measles seroprevalence, spatiotemporal patterns of titers across regions and antibody dynamics among children aged 1-9 years who grew up during varying measles circulation in Madagascar under a one-dose vaccination schedule. We found that measles seroprevalence has generally decreased over this time period.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!